摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 1238394-85-8

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
1238394-85-8
化学式
C9H10F3NO2
mdl
——
分子量
221.179
InChiKey
PYLJGOXLLPFQRN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    286.324±40.00 °C(Press: 760.00 Torr)(predicted)
  • 密度:
    1.295±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.86
  • 重原子数:
    15.0
  • 可旋转键数:
    2.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    42.35
  • 氢给体数:
    1.0
  • 氢受体数:
    3.0

反应信息

  • 作为反应物:
    描述:
    甲基磺酰氯 在 sodium hydride 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 以94%的产率得到2,2,2-trifluoro-1-(5-methoxypyridin-2-yl)-1-methylethyl methanesulfonate
    参考文献:
    名称:
    Discovery of Oxazolobenzimidazoles as Positive Allosteric Modulators for the mGluR2 Receptor
    摘要:
    Novel oxazolobenzimidazoles are described as potent and selective positive allosteric modulators of the metabotropic glutamate receptor 2. The discovery of this class and optimization of its physicial and pharmacokinetic properties led to the identification of potent and orally bioavailable compounds (20 and 21) as advanced leads. Compound 20 (TBPCOB) was shown to have robust activity in a PCP-induced hyperlocomotion model in rat, an assay responsive to clinical antipsychotic treatments for schizophrenia.
    DOI:
    10.1021/ml100115a
  • 作为产物:
    描述:
    (三氟甲基)三甲基硅烷1-(5-甲氧基-2-吡啶)乙酮lithium acetate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 以86%的产率得到
    参考文献:
    名称:
    Discovery of Oxazolobenzimidazoles as Positive Allosteric Modulators for the mGluR2 Receptor
    摘要:
    Novel oxazolobenzimidazoles are described as potent and selective positive allosteric modulators of the metabotropic glutamate receptor 2. The discovery of this class and optimization of its physicial and pharmacokinetic properties led to the identification of potent and orally bioavailable compounds (20 and 21) as advanced leads. Compound 20 (TBPCOB) was shown to have robust activity in a PCP-induced hyperlocomotion model in rat, an assay responsive to clinical antipsychotic treatments for schizophrenia.
    DOI:
    10.1021/ml100115a
点击查看最新优质反应信息